4.1 Article

Surgery, Stereotactic Radiosurgery, and Systemic Therapy in the Management of Operable Brain Metastasis

Journal

NEUROLOGIC CLINICS
Volume 40, Issue 2, Pages 421-436

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ncl.2021.11.002

Keywords

Stereotactic radiosurgery; Surgery; Targeted therapy; Immunotherapy; Brain metastases

Funding

  1. Medtronic Inc
  2. BlueEarth Diagnostics Ltd
  3. Novocure
  4. GT Medical Technologies
  5. AstraZeneca
  6. Exelixis
  7. Viewray Inc
  8. BMS
  9. Bayer
  10. Incyte
  11. Pharmacyclics
  12. Mimivax
  13. Merck
  14. Kiyatec
  15. Insightec
  16. GSK
  17. Xoft
  18. Nuvation
  19. Cellularity
  20. SDP Oncology
  21. Apollomics
  22. Prelude
  23. Janssen

Ask authors/readers for more resources

Brain metastases are the most common brain tumors in adults. Recent advances in understanding molecular biology have allowed for tailored systemic therapies and immunotherapies as treatment options. Improved surgical techniques and innovative radiotherapy approaches have also enhanced patient outcomes. Multidisciplinary care is crucial in managing operable patients with brain metastases in the modern era.
center dot Brain metastases represent the most common brain tumors in adults. center dot Recent advances in our understanding of the molecular biology of metastases versus pri-mary tumors have allowed for tailoring systemic therapies in those with actionable alter-ations and the introduction of immunotherapies has provided additional treatment options for a broad range of malignancies. center dot Technical advances in surgical techniques with intraoperative image guidance and elec-trophysiologic mapping have improved surgical outcomes and innovative radiotherapy approaches, such as preoperative or postoperative stereotactic radiosurgery, continue to improve local control rates. center dot Given the complexity of managing operable patients with brain metastases in the modern era, multi-disciplinary care is critical to improving patient outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available